PMC6930015_01
Flow diagram of the clinical trial, including detailed information on the participants.
CCIDE-11-383-g0001.jpg
PMC6930015_01_CCIDE-11-383-g0001.jpg
F0001
The analysis followed the intent-to-treat protocol and involved all participants who were randomly assigned in their respective groups (Figure 1).